DYN compared with ATEX: revenue, margins and what each company keeps, and the suppliers and customers both name

DYNDyne Therapeutics, Inc.

Mkt capRevenueRevenue

ATEXAnterix Inc.

Mkt capRevenueRevenue

Compare

DYNDyne Therapeutics, Inc.

ATEXAnterix Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DYN

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±16.7%▲+2.51%×0.15

May 11 '26±21.6%▲+4.83%×0.22

Q1 FY26±26.6%▲+3.39%×0.13

Jan 12 '26±10.7%▼−1.74%×0.16

ATEX

2 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 12 '26±11.9%▼−4.45%×0.38

Q1 FY27±12.2%▲+25.72%×2.11

= impliedDYN realized, solidATEX realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q3 FY26

±14.3%

▼−1.45%

×0.10

Q2 FY26±11.9%▲+13.68%×1.15

DYNDyne Therapeutics, Inc.

16.69▼−2.07%· post 16.69

Mkt cap$3.1BRevenue—Revenue—

ATEXAnterix Inc.

90.21▼−1.74%· post 92.26

ClosedOct 30 '26

Mkt cap$1.8BRevenue$2MQ1 FY27Revenue$7MFY26

Compare

ClosedOct 30 '26

DYNDyne Therapeutics, Inc.

ATEXAnterix Inc.

16.69▼−2.07%post 16.69

Price

90.21▼−1.74%post 92.26

$3.1B

Mkt cap

$1.8B

—

Revenue

$2MQ1 FY27

—

Revenue

$7MFY26

DYN16.69▼−2.07%vsATEX90.21▼−1.74%ClosedOct 30 '26